McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
869.00
+12.31 (1.44%)
At close: Aug 14, 2026, 4:00 PM EDT
871.00
+2.00 (0.23%)
After-hours: Aug 14, 2026, 7:52 PM EDT
McKesson Revenue
McKesson had revenue of $105.38B in the quarter ending June 30, 2026, with 7.72% growth. This brings the company's revenue in the last twelve months to $410.98B, up 8.84% year-over-year. In the fiscal year ending March 31, 2026, McKesson had annual revenue of $403.43B with 12.36% growth.
Revenue (ttm)
$410.98B
Revenue Growth
+8.84%
P/S Ratio
0.25
Revenue / Employee
$9,557,744
Employees
43,000
Market Cap
101.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 403.43B | 44.38B | 12.36% |
| Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | 231.05B | 16.73B | 7.81% |
| Mar 31, 2019 | 214.32B | 5.96B | 2.86% |
| Mar 31, 2018 | 208.36B | 9.82B | 4.95% |
| Mar 31, 2017 | 198.53B | 7.65B | 4.01% |
| Mar 31, 2016 | 190.88B | 11.84B | 6.61% |
| Mar 31, 2015 | 179.05B | 41.65B | 30.32% |
| Mar 31, 2014 | 137.39B | 15.20B | 12.44% |
| Mar 31, 2013 | 122.20B | -125.00M | -0.10% |
| Mar 31, 2012 | 122.32B | 10.24B | 9.13% |
| Mar 31, 2011 | 112.08B | 3.38B | 3.11% |
| Mar 31, 2010 | 108.70B | 2.07B | 1.94% |
| Mar 31, 2009 | 106.63B | 4.93B | 4.85% |
| Mar 31, 2008 | 101.70B | 8.73B | 9.39% |
| Mar 31, 2007 | 92.98B | 5.99B | 6.89% |
| Mar 31, 2006 | 86.98B | 7.89B | 9.97% |
| Mar 31, 2005 | 79.10B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cencora | 332.77B |
| Cardinal Health | 254.25B |
| Henry Schein | 13.60B |
| Accendra Health | 2.65B |
| 111, Inc. | 1.65B |
| EDAP TMS | 74.07M |
| Cosmos Health | 69.49M |
| Synergy CHC | 27.70M |
MCK News
- 4 days ago - McKesson price target raised to $933 from $812 at Wells Fargo - TheFly
- 8 days ago - McKesson price target raised to $977 from $966 at Morgan Stanley - TheFly
- 9 days ago - McKesson price target raised to $1,015 from $955 at Baird - TheFly
- 9 days ago - McKesson price target raised to $1,000 from $860 at Evercore ISI - TheFly
- 9 days ago - McKesson price target raised to $1,006 from $989 at TD Cowen - TheFly
- 9 days ago - McKesson price target raised to $1,080 from $1,050 at UBS - TheFly
- 9 days ago - McKesson price target raised to $905 from $885 at Mizuho - TheFly
- 10 days ago - McKesson raises annual profit forecast on strong growth in specialty drug business - Reuters